c-Abl activates p38 MAPK independently of its tyrosine kinase activity: Implications in cisplatin-based therapy.

Source:http://linkedlifedata.com/resource/pubmed/id/17893873

Int. J. Cancer 2008 Jan 15 122 2 289-97

Download in:

View as

General Info

PMID
17893873